Duncan Mc Hale is Chief Medical Officer of Evelo Biosciences, Inc.. Currently has a direct ownership of 16,984 shares of EVLO, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 3,103 shares (Common Stock) at a price of $0.33 per share, resulting in proceeds of $1,023. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17K
0% 3M change
25.0% 12M change
Total Value Held $0

Duncan McHale Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 08 2023
SELL
Open market or private sale
$1,023 $0.33 p/Share
3,103 Reduced 15.45%
16,984 Common Stock
Nov 07 2023
BUY
Exercise of conversion of derivative security
-
6,500 Added 24.45%
20,087 Common Stock
Nov 02 2023
SELL
Open market or private sale
$2,261 $0.33 p/Share
6,854 Reduced 33.53%
13,587 Common Stock
Nov 01 2023
BUY
Exercise of conversion of derivative security
-
12,500 Added 37.95%
20,441 Common Stock
Aug 08 2023
SELL
Open market or private sale
$32,657 $9.51 p/Share
3,434 Reduced 30.19%
7,941 Common Stock
Aug 07 2023
BUY
Exercise of conversion of derivative security
-
6,500 Added 36.36%
11,375 Common Stock
May 08 2023
SELL
Open market or private sale
$8,674 $0.13 p/Share
66,730 Reduced 40.63%
97,516 Common Stock
May 07 2023
BUY
Exercise of conversion of derivative security
-
130,000 Added 44.18%
164,246 Common Stock
May 27 2022
BUY
Open market or private purchase
$49,999 $1.46 p/Share
34,246 Added 50.0%
34,246 Common Stock
DM

Duncan Mc Hale

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on EVLO

Follow Evelo Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EVLO shares.

Notify only if

Insider Trading

Get notified when an Evelo Biosciences, Inc. insider buys or sells EVLO shares.

Notify only if

News

Receive news related to Evelo Biosciences, Inc.

Track Activities on EVLO